ENPP1 and breast neoplasm: Patients in the METABRIC database with breast tumors expressing high levels of ENPP1 mRNA have a significantly worse disease-free survival rate, despite exhibiting a similar distribution across disease stages as the ENPP1-low group (Fig. 1A).